Literature DB >> 25752481

Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation.

Jia-Yi Wei1, Wan-Ming Li, Lin-Lin Zhou, Qiu-Nan Lu, Wei He.   

Abstract

Melatonin induces apoptosis in many different cancer cell lines, including colorectal cancer. However, the precise mechanisms involved remain largely unresolved. In this study, we provide evidence to reveal a new mechanism by which melatonin induces apoptosis of colorectal cancer LoVo cells. Melatonin at pharmacological concentrations significantly suppressed cell proliferation and induced apoptosis in a dose-dependent manner. The observed apoptosis was accompanied by the melatonin-induced dephosphorylation and nuclear import of histone deacetylase 4 (HDAC4). Pretreatment with a HDAC4-specific siRNA effectively attenuated the melatonin-induced apoptosis, indicating that nuclear localization of HDAC4 is required for melatonin-induced apoptosis. Moreover, constitutively active Ca(2+) /calmodulin-dependent protein kinase II alpha (CaMKIIα) abrogated the melatonin-induced HDAC4 nuclear import and apoptosis of LoVo cells. Furthermore, melatonin decreased H3 acetylation on bcl-2 promoter, leading to a reduction of bcl-2 expression, whereas constitutively active CaMKIIα(T286D) or HDAC4-specific siRNA abrogated the effect of melatonin. In conclusion, the present study provides evidence that melatonin-induced apoptosis in colorectal cancer LoVo cells largely depends on the nuclear import of HDAC4 and subsequent H3 deacetylation via the inactivation of CaMKIIα.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CaMKIIα; HDAC4; apoptosis; colorectal cancer; histone acetylation; melatonin

Mesh:

Substances:

Year:  2015        PMID: 25752481     DOI: 10.1111/jpi.12226

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  32 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

3.  Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro.

Authors:  Roberto Pariente; Ignacio Bejarano; Ana Beatriz Rodríguez; José Antonio Pariente; Javier Espino
Journal:  Mol Cell Biochem       Date:  2017-08-17       Impact factor: 3.396

4.  Deacetylation of Glutaminase by HDAC4 contributes to Lung Cancer Tumorigenesis.

Authors:  Tao Wang; Zhuo Lu; Tianyu Han; Yanan Wang; Mingxi Gan; Jian-Bin Wang
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

5.  A combined treatment with melatonin and andrographis promotes autophagy and anticancer activity in colorectal cancer.

Authors:  Yinghui Zhao; Chuanxin Wang; Ajay Goel
Journal:  Carcinogenesis       Date:  2022-04-25       Impact factor: 4.741

6.  Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK/Parkin/mitophagy axis.

Authors:  Li Chen; Liping Liu; Yinghui Li; Jing Gao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-10-25       Impact factor: 2.416

Review 7.  Melatonin: does it have utility in the treatment of haematological neoplasms?

Authors:  Tian Li; Zhi Yang; Shuai Jiang; Wencheng Di; Zhiqiang Ma; Wei Hu; Fulin Chen; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-09-09       Impact factor: 8.739

Review 8.  Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.

Authors:  Wamidh H Talib; Ahmad Riyad Alsayed; Alaa Abuawad; Safa Daoud; Asma Ismail Mahmod
Journal:  Molecules       Date:  2021-04-25       Impact factor: 4.411

Review 9.  Melatonin and its ubiquitous anticancer effects.

Authors:  Sankha Bhattacharya; Krishna Kumar Patel; Deepa Dehari; Ashish Kumar Agrawal; Sanjay Singh
Journal:  Mol Cell Biochem       Date:  2019-08-26       Impact factor: 3.396

10.  Melatonin inhibits gallbladder cancer cell migration and invasion via ERK-mediated induction of epithelial-to-mesenchymal transition.

Authors:  Hongwei Tang; Xiaoyi Shi; Pengfei Zhu; Wenzhi Guo; Jie Li; Bing Yan; Shuijun Zhang
Journal:  Oncol Lett       Date:  2021-06-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.